Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Petrov I"'
Autor:
Adel Aminian, Christoph Naber, Edouard Benit, Luc Janssens, Eugene P. McFadden, Marco Valgimigli, Sergio Leonardi, Ivo Petrov, Ton Slagboom, Patrick W. Serruys, Christian W. Hamm, Gabriel Steg, Paweł Buszman, Marcello Dominici, Leonardo Bolognese, Janusz Prokopczuk, Pascal Vranckx, Dik Heg, Stephan Windecker, Mathias Vrolix, Maurizio Ferrario, Krzysztof Bryniarski, Raffaele Piccolo, Anna Franzone, Aleksander Zurakowski, Christoph Liebetrau, Kurt Huber, Scot Garg, Peter Jüni, Robert-Jan van Geuns, Carlo Tumscitz
Publikováno v:
BMJ Open, 9(3):e026053. BMJ Publishing Group
Leonardi, Sergio; Franzone, Anna; Piccolo, Raffaele; McFadden, Eugene; Vranckx, Pascal; Serruys, Patrick; Benit, Edouard; Liebetrau, Christoph; Janssens, Luc; Ferrario, Maurizio; Zurakowski, Aleksander; van Geuns, Robert-Jan; Dominici, Marcello; Huber, Kurt; Slagboom, Ton; Buszman, Paweł; Bolognese, Leonardo; Tumscitz, Carlo; Bryniarski, Krzysztof; Aminian, Adel; ... (2019). Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY). [Protocol]. BMJ open, 9(3), e026053. BMJ Publishing Group 10.1136/bmjopen-2018-026053
BMJ Open
Leonardi, Sergio; Franzone, Anna; Piccolo, Raffaele; McFadden, Eugene; Vranckx, Pascal; Serruys, Patrick; Benit, Edouard; Liebetrau, Christoph; Janssens, Luc; Ferrario, Maurizio; Zurakowski, Aleksander; van Geuns, Robert-Jan; Dominici, Marcello; Huber, Kurt; Slagboom, Ton; Buszman, Paweł; Bolognese, Leonardo; Tumscitz, Carlo; Bryniarski, Krzysztof; Aminian, Adel; ... (2019). Rationale and design of a prospective substudy of clinical endpoint adjudication processes within an investigator-reported randomised controlled trial in patients with coronary artery disease: the GLOBAL LEADERS Adjudication Sub-StudY (GLASSY). [Protocol]. BMJ open, 9(3), e026053. BMJ Publishing Group 10.1136/bmjopen-2018-026053
BMJ Open
IntroductionThe GLOBAL LEADERS is an open-label, pragmatic and superiority randomised controlled trial designed to challenge the current treatment paradigm of dual antiplatelet therapy (DAPT) for 12 months followed by aspirin monotherapy among patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fdd577bb808fcec31033b5f60e924ec